Frontlight ResearchEarly access
Trial site
West Cancer Center
- 8running trials
- 5closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer7 trials
- Lung cancer3 trials
- Pancreatic cancer2 trials
- Brain metastases1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Melanoma1 trial
- Sarcoma1 trial
- Phase
- Phase 39 trials
- Phase 24 trials
- Status
- Active, not recruiting6 trials
- Completed5 trials
- Recruiting2 trials
- Lead sponsor
- Hoffmann-La Roche4 trials
- Aadi Bioscience, Inc.1 trial
- Actuate Therapeutics Inc.1 trial
- Adlai Nortye Biopharma Co., Ltd.1 trial
- Genentech, Inc.1 trial
- and 5 more
Running trials
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Completed
The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026